Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pyroglutamic acid improves the age associated memory impairment.

S Grioli1, C Lomeo, M C Quattropani

  • 1Cattedra di Patologia Neurologica II dell'Università di Catania, Italy.

Fundamental & Clinical Pharmacology
|January 1, 1990
PubMed
Summary

Pyroglutamic acid (PCA) supplementation shows promise for enhancing verbal memory in older adults experiencing age-related memory decline. This randomized trial found PCA improved specific memory functions compared to placebo over 60 days.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alexithymia and Inflammatory Bowel Disease: A Systematic Review.

Frontiers in psychology·2020
Same author

Relationship between motivation, adherence to diet, anxiety symptoms, depression symptoms and quality of life in individuals with celiac disease.

Journal of psychosomatic research·2019
Same author

Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia : Results of a Multicentre, Double-Blind, Placebo-Controlled Study.

Clinical drug investigation·2016
Same author

A plaster combining diclofenac and heparin: microcirculatory evaluation in 2 models of high-perfusion microangiopathy.

Angiology·2005
Same author

Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.

Annali dell'Istituto superiore di sanita·1996
Same author

G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.

European journal of pharmacology·1995

Area of Science:

  • Neuroscience
  • Gerontology
  • Pharmacology

Background:

  • Age-related memory decline is a common concern in aging populations.
  • Cognitive deficits can significantly impact quality of life.
  • Identifying effective interventions for memory enhancement is crucial.

Purpose of the Study:

  • To evaluate the efficacy of pyroglutamic acid (PCA) in improving memory functions in aged subjects.
  • To compare PCA's effects against a placebo in a controlled trial.

Main Methods:

  • A randomized, double-blind trial was conducted with 40 aged subjects.
  • Participants were divided into two groups: 20 received PCA, and 20 received a placebo.
  • Treatment duration was 60 days, with memory functions assessed at baseline and post-treatment using a battery of 6 memory tasks.

Related Experiment Videos

Main Results:

  • Pyroglutamic acid (PCA) demonstrated effectiveness in improving certain verbal memory functions.
  • Improvements were observed in subjects experiencing age-related memory decline.
  • No significant adverse effects were mentioned in the abstract.

Conclusions:

  • Pyroglutamic acid (PCA) may be a viable option for mitigating age-related memory decline.
  • Further research could explore optimal dosages and long-term effects.
  • PCA shows potential as a therapeutic agent for cognitive enhancement in the elderly.